⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Joan BaijnathMD

Internal Medicine · Palm Beach Gardens, FL 33410

NPI: 1245493485

Share:

43

🟠 Elevated

🤖 ML Fraud Detection Score: 89%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

212

Total Claims

$41K

Drug Cost

24

Beneficiaries

$1,720

Cost/Patient

Risk Score Breakdown 43/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+2281%

Opioid rate vs peers

53.3% vs 2.2% avg

+22%

Cost per patient vs peers

$1,720 vs $1,411 avg

+11%

Brand preference vs peers

11.8% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

🤖

ML fraud detection score of 89% indicates prescribing patterns with significant similarity to confirmed fraud cases. 18 out of 20 decision trees flagged this provider.

⚠️

Opioid prescribing rate is 2,281% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

53.3%

Opioid Rate

113

Opioid Claims

$31K

Opioid Cost

33.6%

Long-Acting Rate

This provider's opioid prescribing rate of 53.3% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

88% generic

Brand: 25 claims · $33K

Generic: 187 claims · $8,736

Patient Profile

63

Avg Age

Female

1.92

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About